National Bank Of Canada Omeros Corp Transaction History

National Bank Of Canada

  • $72.7 Billion
  • Q3 2024

Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2023

Jul 26, 2023
BUY
$4.45 - $7.57 $2.5 Million - $4.25 Million
560,800 New
560,800 $3.05 Million
Q3 2022

Oct 13, 2022
BUY
$3.09 - $7.46 $68,289 - $164,866
22,100 Added 230.21%
31,700 $100,000
Q2 2022

Jul 28, 2022
BUY
$1.92 - $6.28 $18,432 - $60,288
9,600 New
9,600 $26,000

Others Institutions Holding OMER

# of Institutions
120
Shares Held
25.6M
Call Options Held
228K
Put Options Held
630K
View Full List

About OMEROS CORP

OMER Quotes by TradingView
  • Ticker OMER
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 62,730,000
  • Market Cap $611M
  • Description
  • Omeros Corporation, a commercial-stage biopharmaceutical company, discovers, develops, and commercializes small-molecule and protein therapeutics, and orphan indications targeting inflammation, complement-mediated diseases, cancers related to dysfunction of the immune system, and addictive and compulsive disorders. The company's clinical program...
More about OMER
Track This Portfolio

Track National Bank Of Canada Portfolio

Follow National Bank Of Canada and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of National Bank Of Canada , based on Form 13F filings with the SEC.

News

Stay updated on National Bank Of Canada with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email